Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
Olema Pharmaceuticals
OLMA
$977M
| $83K | ﹤0.01% |
3,015
+297
| +11% | +$8.02K |
|
4377
Pliant Therapeutics
PLRX
$65M
| $83K | ﹤0.01% |
4,927
+708
| +17% | +$15K |
|
|
SVM
4378
Silvercorp Metals
SVM
$2.02B
| $83K | ﹤0.01% |
21,845
+21,578
| +8,082% | +$97.7K |
|
4379
Teekay
TK
$996M
| $83K | ﹤0.01% |
22,762
+19,249
| +548% | +$60.6K |
|
4380
Veru
VERU
$35.5M
| $83K | ﹤0.01% |
975
+436
| +81% | +$34.6K |
|
|
ITIC
4381
Investors Title Co
ITIC
$560M
| $82K | ﹤0.01% |
450
+88
| +24% | +$15.9K |
|
|
YI
4382
111 Inc
YI
$31.3M
| $82K | ﹤0.01% |
1,328
+354
| +36% | +$23.6K |
|
|
AWF
4383
AllianceBernstein Global High Income Fund
AWF
$869M
| $81K | ﹤0.01% |
6,620
-15,094
| -70% | -$187K |
|
4384
CRA International
CRAI
$1.23B
| $81K | ﹤0.01% |
812
+472
| +139% | +$42.6K |
|
4385
Commercial Vehicle Group
CVGI
$147M
| $81K | ﹤0.01% |
8,524
+6,735
| +376% | +$63.7K |
|
4386
Vuzix
VUZI
$178M
| $81K | ﹤0.01% |
7,778
-28,020
| -78% | -$375K |
|
|
XXII
4387
22nd Century Group
XXII
$1.28M
| – | – |
0
| – | – |
|
4388
BrightView Holdings
BV
$1.24B
| $80K | ﹤0.01% |
5,434
-4,821
| -47% | -$73.6K |
|
4389
iShares Morningstar Small-Cap Value ETF
ISCV
$695M
| $80K | ﹤0.01% |
1,407
-391
| -22% | -$22.3K |
|
4390
Lifestance Health
LFST
$4.15B
| $80K | ﹤0.01% |
5,546
+4,696
| +552% | +$90.4K |
|
|
MAPS
4391
DELISTED
WM TECHNOLOGY INC A
MAPS
| $80K | ﹤0.01% |
5,534
+4,934
| +822% | +$71.3K |
|
4392
NRC Health Common Stock
NRC
$405M
| $80K | ﹤0.01% |
1,896
+787
| +71% | +$39.6K |
|
4393
Invesco Financial Preferred ETF
PGF
$674M
| $80K | ﹤0.01% |
4,234
-9,876
| -70% | -$189K |
|
4394
Axogen
AXGN
$2.2B
| $79K | ﹤0.01% |
4,994
+2,470
| +98% | +$44.4K |
|
4395
Invesco Dividend Achievers ETF
PFM
$789M
| $79K | ﹤0.01% |
+2,186
| New | +$81.2K |
|
4396
GeneDx Holdings
WGS
$1.89B
| $79K | ﹤0.01% |
+317
| New | +$109K |
|
|
SRTA
4397
Strata Critical Medical Inc
SRTA
$421M
| $78K | ﹤0.01% |
+7,523
| New | +$65.7K |
|
4398
Byline Bancorp
BY
$1.78B
| $78K | ﹤0.01% |
3,179
+1,504
| +90% | +$35.9K |
|
4399
Cass Information Systems
CASS
$716M
| $78K | ﹤0.01% |
1,875
+718
| +62% | +$30.6K |
|
4400
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.97B
| $78K | ﹤0.01% |
3,250
-3,897
| -55% | -$92.1K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.